0001209191-21-049763.txt : 20210804
0001209191-21-049763.hdr.sgml : 20210804
20210804183248
ACCESSION NUMBER: 0001209191-21-049763
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Eli
CENTRAL INDEX KEY: 0001534264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40656
FILM NUMBER: 211145597
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001858848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813789973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-865-2066
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001858848
Tenaya Therapeutics, Inc.
TNYA
0001534264
Casdin Eli
C/O TENAYA THERAPEUTICS, INC.
171 OYSTER POINT BLVD., 5TH FLR.
SOUTH SAN FRANCISCO
CA
94080
1
0
1
0
Common Stock
2021-08-03
4
C
0
2374849
0.00
A
2374849
I
See Footnotes
Common Stock
2021-08-03
4
P
0
850000
15.00
A
3224849
I
See Footnotes
Common Stock
2021-08-03
4
C
0
361969
0.00
A
361969
I
See Footnotes
Series B Preferred Stock
0.00
2021-08-03
4
C
0
2012880
D
Common Stock
2012880
0
I
See Footnotes
Series C Preferred Stock
0.00
2021-08-03
4
C
0
361969
D
Common Stock
361969
0
I
See Footnotes
Series C Preferred Stock
0.00
2021-08-03
4
C
0
361969
D
Common Stock
361969
0
I
See Footnotes
These shares are held directly by Casdin Partners Master Fund, L.P.(CPMF).
Casdin Capital, LLC is the investment advisor to CPMF and CPGEF. Casdin Partners GP, LLC is the general partner of CPMF. Casdin Private Growth Equity Fund GP, LLC is the general partner of CPGEF. The Reporting Person is the managing member of Casdin Capital, LLC, Casdin Partners GP, LLC and Casdin Private Growth Equity Fund GP, LLC and may be deemed to have voting and investment power with respect to the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
These shares are held directly by Casdin Private Growth Equity Fund, L.P. (CPGEF).
Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date.
/s/ Eli Casdin
2021-08-03